Sol J. Barer, Director at Aevi Genomic Medicine, Inc. (GNMX), bought 842,064 shares at $1.26 ($1.1M) on 2017-10-17, disclosed to the SEC on 2017-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.26 | 421,032 | $531K | 50.0% |
| 2 | $1.26 | 421,032 | $531K | 50.0% |
| Total | $1.26 avg | 842,064 | $1.1M | 100% |
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |